Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean‐Jacques Grob, Лев Вадимович Демидов et al. · The Lancet · 2012

Cited by 2,989 works. doi:10.1016/s0140-6736(12)60868-x

Authors

References